H. Donners

发表

International Network for Comparison of HIV Neutralization Assays: The NeutNet Report

Q. Sattentau, S. Zolla-Pazner, D. Montefiori, 2009, PloS one.

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection

G. Vanham, G. Leroux-Roels, L. Heyndrickx, 2007, Journal of Immunological Methods.

Dissecting the Neutralizing Antibody Speciﬁcities of Broadly Neutralizing Sera from Human Immunodeﬁciency Virus Type 1-Infected Donors (cid:1)

D. Richman, R. Doms, D. Burton, 2007 .

Inter‐subtype cross‐neutralizing antibodies recognize epitopes on cell‐associated HIV‐1 virions

D. Davis, G. van der Groen, B. Willems, 2003, Journal of medical virology.

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Douglas D. Richman, Welkin E. Johnson, Dennis R. Burton, 2007, Journal of Virology.

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from 1 HIV-1 infected donors 2 *

R. Doms, D. Burton, G. Shaw, 2007 .

Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates

M. Ntemgwa, D. Davis, G. van der Groen, 2006, Journal of medical virology.

Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV‐1 group M primary isolates and can be detected in neutralization assays with extended incubation phases

L. Heyndrickx, R. Colebunders, D. Davis, 2003, Journal of medical virology.

Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.

G. Vanham, G. Leroux-Roels, L. Heyndrickx, 2007, Antiviral research.

The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases.

D. Davis, G. van der Groen, B. Willems, 2003, Vaccine.

Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120.

J. Heeney, G. Vanham, S. Barnett, 2004, Vaccine.

Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1.

R. Colebunders, D. Davis, G. van der Groen, 2002, AIDS.